ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
12.99
-0.25 (-1.89%)
Aug 31, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 37.48 | 45.67 | 59.41 | 23.38 | 66.84 | 226.01 |
Short-Term Investments | 227.28 | 235.82 | 196.55 | 184.8 | 139.43 | 10.97 |
Cash & Short-Term Investments | 264.76 | 281.49 | 255.96 | 208.19 | 206.27 | 236.98 |
Cash Growth | -6.28% | 9.97% | 22.95% | 0.93% | -12.96% | -19.29% |
Prepaid Expenses | 8.93 | 6.98 | 6.29 | 4.41 | 4.18 | 3.54 |
Total Current Assets | 273.7 | 288.47 | 262.25 | 212.6 | 210.46 | 240.52 |
Property, Plant & Equipment | 2.24 | 9.07 | 11.3 | 12.01 | 14.24 | 14.21 |
Long-Term Investments | 122.8 | 110.76 | - | 26.85 | 21.95 | 43.39 |
Other Long-Term Assets | 5.95 | 0.59 | 0.59 | 0.55 | 0.53 | 0.52 |
Total Assets | 404.69 | 408.89 | 274.14 | 252.01 | 247.18 | 298.64 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.87 | 3.82 | 1.55 | 0.94 | 1.32 | 1.89 |
Accrued Expenses | 13.56 | 13.26 | 20.12 | 16.76 | 11.41 | 11.34 |
Current Portion of Leases | 3.33 | 3.33 | 3.18 | 2.75 | 2.66 | 1.93 |
Total Current Liabilities | 20.76 | 20.42 | 24.85 | 20.46 | 15.39 | 15.15 |
Long-Term Leases | 2.67 | 4.11 | 6.17 | 7.46 | 9.44 | 10.52 |
Total Liabilities | 23.43 | 24.53 | 31.02 | 27.92 | 24.83 | 25.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 |
Additional Paid-In Capital | 1,152 | 1,076 | 805.51 | 658.75 | 557.87 | 518.18 |
Retained Earnings | -769.5 | -692.24 | -562.77 | -434.93 | -334.23 | -245.11 |
Comprehensive Income & Other | -1.02 | 0.79 | 0.38 | 0.26 | -1.29 | -0.1 |
Total Common Equity | 381.26 | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 |
Shareholders' Equity | 381.26 | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 |
Total Liabilities & Equity | 404.69 | 408.89 | 274.14 | 252.01 | 247.18 | 298.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6 | 7.44 | 9.36 | 10.21 | 12.1 | 12.44 |
Net Cash (Debt) | 258.76 | 274.05 | 246.6 | 197.97 | 194.17 | 224.54 |
Net Cash Growth | -5.71% | 11.13% | 24.56% | 1.96% | -13.52% | -23.52% |
Net Cash Per Share | 2.49 | 3.12 | 3.54 | 3.85 | 4.90 | 5.92 |
Filing Date Shares Outstanding | 103.65 | 100.36 | 71.03 | 67.38 | 45.09 | 39.43 |
Total Common Shares Outstanding | 103.64 | 98.53 | 71.02 | 54.87 | 45.09 | 39.43 |
Working Capital | 252.94 | 268.05 | 237.4 | 192.14 | 195.07 | 225.37 |
Book Value Per Share | 3.68 | 3.90 | 3.42 | 4.08 | 4.93 | 6.92 |
Tangible Book Value | 381.26 | 384.36 | 243.12 | 224.09 | 222.35 | 272.98 |
Tangible Book Value Per Share | 3.68 | 3.90 | 3.42 | 4.08 | 4.93 | 6.92 |
Machinery | 8.35 | 8 | 8.36 | 7.39 | 7.07 | 5.69 |
Leasehold Improvements | 2.07 | 2.07 | 2.04 | 1.97 | 1.98 | 1.71 |